Seiko Epson Corporation (6724.T)
JPY 1910.5
(-0.62%)
JPY 1910.5
(-0.62%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1313.99 Billion | 1330.33 Billion | 1128.91 Billion | 995.94 Billion | 1043.6 Billion | 1089.67 Billion |
| Cost of Revenue | 874.52 Billion | 863.68 Billion | 710.46 Billion | 643.56 Billion | 681.6 Billion | 677.06 Billion |
| Gross Profit | 439.47 Billion | 466.65 Billion | 418.45 Billion | 352.37 Billion | 362 Billion | 412.61 Billion |
| Operating Expenses | 374.75 Billion | 369.6 Billion | 323.97 Billion | 304.72 Billion | 322.52 Billion | 341.25 Billion |
| Selling, General and Administrative Expenses | 330.47 Billion | 371.54 Billion | 328.81 Billion | 290.73 Billion | 321.13 Billion | 342.11 Billion |
| Research and Development Expenses | 44.28 Billion | 46.67 Billion | 49.28 Billion | 46.47 Billion | 49.2 Billion | 58.26 Billion |
| Other Expenses | - | - | -4.84 Billion | 99 Million | 77 Million | 99 Million |
| Cost and Expenses | 1249.27 Billion | 1233.28 Billion | 1034.43 Billion | 948.28 Billion | 1004.12 Billion | 1018.32 Billion |
| Operating Income | 64.72 Billion | 97.04 Billion | 94.47 Billion | 47.65 Billion | 39.47 Billion | 71.35 Billion |
| Interest Expense | 2.71 Billion | 2.03 Billion | 2.12 Billion | 4.13 Billion | 2.15 Billion | 1.86 Billion |
| Income Tax Expense | 17.47 Billion | 28.7 Billion | 4.85 Billion | 13.93 Billion | 31.88 Billion | 17.99 Billion |
| Earnings before Tax | 70.09 Billion | 103.75 Billion | 97.16 Billion | 44.93 Billion | 39.71 Billion | 72.04 Billion |
| Net Income | 52.61 Billion | 75.04 Billion | 92.28 Billion | 30.92 Billion | 7.73 Billion | 53.71 Billion |
| Earnings Per Share Basic | 158.68 | 220.75 | 266.72 | 89.38 | 22.26 | 152.48 |
| Earnings Per Share Diluted | 158.66 | 220.70 | 266.64 | 89.35 | 22.25 | 152.44 |
| Weighted Average Shares Outstanding | 331.58 Million | 339.95 Million | 346 Million | 345.96 Million | 347.39 Million | 352.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 331.63 Million | 340.02 Million | 346.11 Million | 346.07 Million | 347.51 Million | 352.34 Million |
| Gross Margin | 0.33 | 0.35 | 0.37 | 0.35 | 0.35 | 0.38 |
| EBIT Margin | 0.11 | 0.13 | 0.15 | 0.12 | 0.11 | 0.12 |
| Profit Margin | 0.04 | 0.06 | 0.08 | 0.03 | 0.01 | 0.05 |
| EBITDA | 140.69 Billion | 173.67 Billion | 162.94 Billion | 116.12 Billion | 109.34 Billion | 129.25 Billion |
| Earnings Before Tax Margin | 0.05 | 0.07 | 0.08 | 0.05 | 0.04 | 0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 337.58 Billion | 336.61 Billion | 321.89 Billion | 1313.99 Billion | 353.56 Billion | 323.69 Billion |
| Cost of Revenue | 211.82 Billion | 216.66 Billion | 210.28 Billion | 874.52 Billion | 222.07 Billion | 217.86 Billion |
| Gross Profit | 125.76 Billion | 119.94 Billion | 111.6 Billion | 439.47 Billion | 131.49 Billion | 105.83 Billion |
| Operating Expenses | 98.21 Billion | 97.47 Billion | 101.21 Billion | 374.75 Billion | 107.72 Billion | 97.6 Billion |
| Selling, General and Administrative Expenses | 98.21 Billion | 96.44 Billion | 90.42 Billion | - | 101.59 Billion | 97 Billion |
| Research and Development Expenses | - | - | 10.78 Billion | - | 10.9 Billion | 117 Million |
| Other Expenses | - | 1.03 Billion | - | - | - | - |
| Cost and Expenses | 310.04 Billion | 314.14 Billion | 311.5 Billion | 1249.27 Billion | 329.8 Billion | 315.47 Billion |
| Operating Income | 27.54 Billion | 22.46 Billion | 10.39 Billion | 64.72 Billion | 23.76 Billion | 8.22 Billion |
| Interest Expense | 6.51 Billion | 607 Million | 842 Million | 2.71 Billion | 3.68 Billion | 561 Million |
| Income Tax Expense | 1.84 Billion | 7.72 Billion | 301 Million | 17.47 Billion | 6.29 Billion | 2.79 Billion |
| Earnings before Tax | 5.95 Billion | 26.88 Billion | 10.45 Billion | 70.07 Billion | 21.28 Billion | 10.08 Billion |
| Net Income | 4.11 Billion | 19.16 Billion | 10.14 Billion | 52.61 Billion | 14.98 Billion | 7.29 Billion |
| Earnings Per Share Basic | 12.42 | 57.78 | 30.60 | - | 45.20 | 21.99 |
| Earnings Per Share Diluted | 12.42 | 57.77 | 30.60 | - | 45.19 | 21.98 |
| Weighted Average Shares Outstanding | 331.66 Million | 331.66 Million | 331.62 Million | 331.58 Million | 331.62 Million | 331.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 331.66 Million | 331.66 Million | 331.66 Million | 331.63 Million | 331.65 Million | 331.64 Million |
| Gross Margin | 0.37 | 0.36 | 0.35 | 0.33 | 0.37 | 0.33 |
| EBIT Margin | 0.08 | 0.12 | 0.09 | - | 0.12 | 0.09 |
| Profit Margin | 0.01 | 0.06 | 0.03 | 0.04 | 0.04 | 0.02 |
| EBITDA | 27.99 Billion | 40.06 Billion | 27.67 Billion | - | 42.15 Billion | 27.78 Billion |
| Earnings Before Tax Margin | 0.08 | 0.07 | 0.03 | 0.05 | 0.07 | 0.03 |
JUBLPHARMA
EKH
3611
3991
EVEX-WT
PPPM